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Abstract Peroxynitrite, a reactive oxidising species resulting
from a reaction between nitric oxide and the superoxide anion,
modifies proteins by nitration of certain amino acids such as
tyrosine. Tissue factor (TF), a transmembrane protein, is
expressed on cells under inflammatory conditions and initiates
the coagulation cascade. The extracellular domain of TF is rich
in tyrosine. Exposure of recombinant TF and cellular TF to
peroxynitrite was associated with a reduction in procoagulant
activity. This was accompanied by an elevated level of
nitrotyrosine residues. Peroxynitrite may have a protective role
by attenuation of the thrombotic properties of TF.
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1. Introduction
Nitric oxide reacts with the superoxide anion to form the
potent oxidising species peroxynitrite [1]. Peroxynitrite modi-
¢es proteins by nitration of speci¢c amino acid residues, in
particular the ortho positions of tyrosine residues to form
nitrotyrosine [2]. Phenylalanine may also be nitrated and tryp-
tophan to a limited extent whereas sulphydryl groups are
readily oxidised to sulphoximes. These events may, in turn,
in£uence the biological activity of proteins [3]. Nitrotyrosine
has been detected in a number of human pathologies includ-
ing Alzheimer’s disease [4] and rheumatoid arthritis [5] and
thus could be a useful marker for the presence of peroxynitrite
in vivo. Nitrotyrosine residues have also been detected in
atherosclerotic plaques, but not in normal blood vessels, sug-
gesting peroxynitrite plays a role in atherosclerosis [6]. Per-
oxynitrite oxidises low density lipoprotein, making it recog-
nisable to the macrophage scavenger receptor leading to foam
cell formation [7]. There is evidence that NO and peroxynitrite
are formed by bovine aortic endothelial cells [8], by rat macro-
phages [9] and more recently by human macrophages [10].
Stimulated human neutrophils are reported to release NO
and O23W at rates that favour the formation of peroxynitrite
[11] and may also be a source of this oxidant in vivo. Protein
bound nitrotyrosine has been detected using an ELISA tech-
nique in normal human plasma, in the range of 120 nM, at
least half of which is bound to albumin [12].
Tissue factor (TF), a transmembrane glycoprotein (47 kDa)
which initiates the blood coagulation by acting as a receptor
for coagulation Factor VII, may have a separate role in angio-
genesis and neointima formation [13,14]. TF is expressed on
monocytes following exposure to bacterial lipopolysaccharide
[14,15], and from endothelial cells and macrophages exposed
to oxidised LDL [16,17]. It has an extracellular (active) do-
main of 219 amino acids, which initiates the coagulation cas-
cade, a short membrane spanning domain and an intracellular
domain of 21 amino acids [18,19]. The extracellular domain of
TF has 12 tyrosine residues, eight of which are exposed and
thus susceptible to attack by peroxynitrite. The importance of
speci¢c tyrosine residues in this domain of TF and the coag-
ulation response has been reported as well as phenylalanine
and possibly tryptophan [19].
In this study, peroxynitrite was shown to attenuate the pro-
coagulant activity of TF in parallel with the increased nitra-
tion of its tyrosine residues measured by ELISA.
2. Materials and methods
Materials and cells were obtained from the following sources: re-
combinant TF (rTF) (Baxter Diagnostics Inc., Deer¢eld, Illinois,
USA), polyclonal anti-nitrotyrosine IgG (TCS Biologicals Ltd, Bo-
tolph Claydon, Bucks, UK), THP-1 monocytes (European Collection
of Animal Cell Culture, Salisbury, Wilts, UK), cell culture reagents,
phosphate bu¡ered saline (PBS) and Versene (Gibco, Paisley, Scot-
land), phorbol-12-myristate-13 acetate (PMA) (Sigma Chemical Co.,
Poole, Dorset, UK), Nutridoma HU (Boehringer Mannheim UK,
Lewes, Sussex, UK). All solutions were prepared with de-ionised
H2O.
2.1. Preparation of peroxynitrite
Peroxynitrite was prepared by mixing NaNO2, H2O2 and HNO3
and passing the solution into NaOH: excess H2O2 removed by ¢lter-
ing through a manganese oxide column, as described by others
although traces may remain [20]. Authentic peroxynitrite was main-
tained at pH 10, but on dilution at pH 7.4 and addition to recombi-
nant TF (rTF), large losses would have occurred in the amount of
peroxynitrite delivered. Decomposed peroxynitrite was prepared by
neutralisation at pH 7.4: the pH was then adjusted back to pH 10
by addition of NaOH and this was used as a control. The concen-
tration of peroxynitrite in the stock solutions was determined by
measuring its absorption at 302 nm using the O of 1670 mol/l1Wcm1.
2.2. Exposure of rTF to peroxynitrite
rTF was diluted in H2O to give a stock solution of 100 Wg protein/
ml and exposed to peroxynitrite or decomposed peroxynitrite at con-
centrations between 0^3 mM, diluted from a stock solution into phos-
phate bu¡ered saline (PBS) and added within the space of 5 s by rapid
vortexing. The controls were rTF treated with PBS pH 7.4.
2.3. Spectrophotometric analysis of tissue factor exposed to peroxyni-
trite
The UV and visible absorption spectra of rTF exposed to perox-
ynitrite and decomposed peroxynitrite, were scanned between 320^620
nm on a Beckman DU70 spectrophotometer, against a blank of H2O,
following neutralisation to pH 7. This was compared to the changes in
absorbance when peroxynitrite was added to free L-tyrosine and L-
tryptophan.
The £uorescence spectra of L-tryptophan and rTF were also meas-
ured with emission wavelength of 340 nm [21] and scanning from 320^
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410 on a Perkin Elmer MPF44B £uorimeter and repeated on rTF
before and after exposure to peroxynitrite or its decomposed control.
In all cases, the e¡ects of hydrogen peroxide were determined on these
spectra, in the event that traces remained in the peroxynitrite. Similar
traces of the peroxide would also be found in the decomposed per-
oxynitrite.
2.4. Measurement of nitrotyrosine residues
Immuno-reactive nitrotyrosine residues in rTF following exposure
to various concentrations of peroxynitrite were quanti¢ed by compet-
itive ELISA assay as recently described [22]. A standard curve was
constructed using nitrated bovine serum albumin (NO2-BSA) at a
series of dilutions. Competition assays were performed by addition
of appropriate samples of peroxynitrite treated rTF instead of NO2-
BSA and inhibition of the antibody binding determined from the
standard curve.
Measurement of nitrotyrosine was also made on the cytosolic and
membrane proteins of human THP-1 monocytes following exposure
to peroxynitrite (0^100 WM). The cells were sonicated by exposure to
two intervals of ultrasound in a one-minute period, followed by cen-
trifugation at 2000Ug for 10 min to separate the cytosol and the total
membrane fraction. The membrane fraction was washed 3U with PBS
prior to solubilisation in 1% CHAPS bu¡er [23].
2.5. Measurement of procoagulant activity
The procoagulant activity of rTF which had been exposed to per-
oxynitrite and decomposed peroxynitrite was measured using the one-
stage prothrombin time assay [24]. rTF samples were diluted (¢nal
concentration of 2 Wg protein/ml) and the procoagulant activity quan-
ti¢ed by reference to a rTF standard curve constructed by plotting log
TF (units/ml) versus log t (clotting time in s). These data were com-
pared to the control values (rTF exposed to PBS) and the degree of
inhibition of procoagulant activity calculated from the equation:
% inhibition  initial activity3residual activity
initial activity
:
All the assays were completed within 10 min of addition of perox-
ynitrite to the rTF.
2.6. Induction of tissue factor activity in THP-1 monocytes
THP-1 monocytes were cultured as described previously [25]. Cells
were seeded 24 h prior to experiment in serum free media supple-
mented with Nutridoma HU (1% v/v), at 0.5U106 cells/ml in 25 cm2
£asks. Cells were stimulated with 10 nM PMA for 4 h and adherent
cells removed by the addition of Versene. The cells were washed
once in PBS and resuspended to 107 cells/ml and were exposed to
0^100 WM peroxynitrite and decomposed peroxynitrite, which had
been diluted from stock solution in PBS. The procoagulant activity
was determined by the one-stage prothrombin time assay and com-
pared to control cells (PBS addition only). The percentage inhibition
was determined as described previously.
2.7. Measurement of lipid peroxides
rTF is dispersed in a small amount of lipid which is necessary for
the biological activity of this protein. Lipid peroxidation was esti-
mated by the FOX assay [26] within 10 min of addition of the per-
oxynitrite.
3. Results
3.1. Spectrophotometric measurements after nitration of rTF
with peroxynitrite
The UV absorption spectrum of rTF shows two major
peaks at 230 and 278 nm which are reminiscent of those of
tryptophan, but may include peaks of tyrosine at neutral pH:
these did not change signi¢cantly on addition of peroxynitrite
up to 3 mM (not shown). In the visible region, rTF did not
show strong absorbance (Fig. 1a), but on addition of 3 mM
peroxynitrite a peak appeared at 350 nm with a smaller peak
at 410^440 nm region (Fig. 1b), the latter corresponding to
the visible absorption spectra of nitrotyrosine (Fig. 1c). Addi-
tion of 3 mM decomposed peroxynitrite to rTF (Fig. 1d) led
to the appearance of the peak at 350 nm which may be at-
tributable in part to a contaminant in peroxynitrite: there was
no peak at 410^440 nm. Lower concentrations of peroxyni-
trite (30^300 WM) showed little change in absorption at any of
these wavelengths.
The £uorometric spectra of rTF suggest that tryptophan
was modi¢ed to a very limited extent by the addition of 300
WM peroxynitrite (Fig. 2) but was largely eliminated by the
addition of 3 mM peroxynitrite. Decomposed peroxynitrite
decreased £uorescence to some extent, but less than for active
peroxynitrite. No change in £uorescence was noted in the
presence of H2O2 (not shown) at concentrations which were
the maximum assuming no steps were taken to remove it
during peroxynitrite synthesis, 0^12 mM.
3.2. Elevated levels of nitrotyrosine residues in TF exposed to
peroxynitrite
The spectrophotometric determinations were insu⁄ciently
sensitive for quanti¢cation of the extent of nitration, but
gave an indication that modi¢cations of tyrosine and trypto-
phan may occur with addition of peroxynitrite. The sensitive
competitive ELISA procedure for nitrotyrosine was used,
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Fig. 1. Identi¢cation of modi¢cation of rTF by peroxynitrite using
visible spectroscopy. Absorption spectra of a: unmodi¢ed rTF at
100 Wg protein/ml; b: rTF modi¢ed by addition of 3 mM peroxyni-
trite; c: rTF with addition of 3 mM decomposed peroxynitrite; d:
100 WM 3-nitrotyrosine. The results are typical of at least six inde-
pendent experiments.
Fig. 2. The in£uence of peroxynitrite on tryptophan £uorescence of
rTF. rTF £uorescence was measured with an excitation wavelength
of 340 nm. The £uorescence over a range of wavelengths was meas-
ured before (a) and after addition of peroxynitrite (¢nal concentra-
tion) at 300 WM (c) and 3 mM (e) or decomposed peroxynitrite at
the same initial concentrations, (b) and (d) respectively. These re-
sults are from one experiment typical of three independent experi-
ments.
J.M. Adam et al./FEBS Letters 429 (1998) 347^350348
therefore, as a convenient procedure for detection of protein
modi¢cation by peroxynitrite at low concentrations. Only low
levels of nitration of tyrosine in rTF were observed at 300 WM
peroxynitrite, suggesting a high proportion of this nitrating
species was lost during mixing (Fig. 3). Exposure of rTF to
3 mM peroxynitrite showed a large increase in nitrotyrosine.
Decomposed peroxynitrite did not cause nitration tyrosine
residues in rTF compared to controls where only bu¡er was
used. There were no increases in the oxidation of the lipid
associated with the rTF as detected by the assay for lipid
peroxides 10 min after addition of the peroxynitrite (not
shown).
Nitration of proteins was determined in THP-1 cells to
which 100 WM peroxynitrite was added, but not with decom-
posed peroxynitrite. Low levels of nitration were detected in
the membranes of these cells (100 nmol nitrotyrosine/mg pro-
tein) which was increase 200-fold by the addition of the per-
oxynitrite. Levels of nitrotyrosine were below the limits of
detection in the cytosolic proteins and were not increased to
a signi¢cant extent. At lower concentrations of peroxynitrite
(30 WM), small rises in nitration of the membrane fraction
were detectable, but did not reach statistical signi¢cance.
3.3. Reduction in the procoagulant activity of rTF exposed to
peroxynitrite
The exposure of rTF (100 Wg protein/ml) to 0^3 mM per-
oxynitrite resulted in a concentration dependent inhibition of
procoagulant activity compared to that of the control sample,
almost complete inhibition attained at 3 mM peroxynitrite
and signi¢cant inhibition at 30 WM and above (Fig. 4). Ex-
posure to decomposed peroxynitrite resulted in a small en-
hancement in procoagulant activity (Fig. 4). This enhance-
ment is not caused by nitrate or nitrite, or indeed a mixture
of the two, when these were tested separately (not shown), nor
was it an e¡ect of H2O2 0^12 mM (not shown).
3.4. Reduction in cell surface tissue factor activity following
exposure to peroxynitrite
Monocytic THP-1 cells were pre-treated with 10 nM PMA
for 4 h to induce an increased expression of the tissue factor
activity on the cell surface. These cells exhibit some procoa-
gulant activity even when unstimulated. This activity was ab-
sent if Factor VII de¢cient plasma was used in the coagula-
tion assay, showing that the procoagulant activity was due to
tissue factor (Fig. 5). Inhibition of PCA of cell surface TF was
attained at concentrations as low as 10 WM peroxynitrite and
an increase in inhibition accompanied higher concentrations
of peroxynitrite. The addition of peroxynitrite at concentra-
tions above 100 WM resulted in some cell lysis and therefore
measurements at higher concentrations were not made.
4. Discussion
The nitration of proteins has been associated extensively
with pathological conditions related to in£ammation such as
atherosclerosis and arthritis [5,6]. However, this may only be
appropriate when there is an excess of nitration. Excessive
formation of peroxynitrite may give rise to extensive modi¢-
cations of proteins and lipids, and ultimately become toxic to
the cells. Nitration of tyrosine residues may arise as the result
of the release of peroxynitrite from normal cells at low con-
centrations, but other sources of nitration are possible, e.g.
from prostaglandin H synthase [27] and myeloperoxidase [28].
Indeed, low levels of nitration were detected in this study in
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Fig. 5. The in£uence of the modi¢cation of TF activity expressed
on the cell surface of a human monocytic cell line by peroxynitrite.
Human monocytic THP-1 cells in suspension culture were treated
with peroxynitrite (0^100 WM) or decomposed peroxynitrite for
10 min and the cell surface activity of the intact cells measured us-
ing the one-stage prothrombin test. The results are the means
þ S.E.M. of at least three independent experiments.
Fig. 4. The in£uence of the modi¢cation of rTF by peroxynitrite on
its procoagulant activity. rTF (100 Wg/ml) was exposed to a range
of concentrations of peroxynitrite or decomposed peroxynitrite
(300 WM) for a period of 10 min after which the procoagulant activ-
ity was measured using the one-stage prothrombin time assay. The
extent of inhibition or activation of the rTF following modi¢cation
was measured against the control where only bu¡er was added. The
results are expressed as the means þ S.E.M. of four independent ex-
periments.
Fig. 3. The nitration of the tyrosine residues of rTF by peroxyni-
trite. rTF (100 Wg protein/ml) was incubated with peroxynitrite (0,
30, 300 and 3000 WM) or decomposed peroxynitrite (300 WM) for a
period of 10 min after which the extent of tyrosine nitration was de-
termined by an ELISA procedure using nitrated bovine serum albu-
min as the standards. The values are expressed as the means
þ S.E.M. of at least four independent experiments.
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the membranes and cytosol of monocytes which were not
exposed to exogenous peroxynitrite: this was also observed
in resting platelets [29]. The fact that the nitrated proteins
are present in normal plasma and other biological £uids
[12], strongly suggests that low levels of peroxynitrite may
be released from cells in vivo or that nitration arises from
the enzymic processes mentioned above. Increased nitration
of cellular proteins may occur during normal physiological
process, e.g. the activation of blood platelets by collagen or
thrombin [29]. A physiological role of nitration has not been
established.
In the current study, the nitration of tyrosine residues was
associated with the reduction in the procoagulant activity of
TF. However, at lower concentrations of peroxynitrite there
was some inhibition of procoagulant activity with only very
modest increases to the nitration of tyrosine. This may be
because only certain key tyrosine residues are important to
the procoagulant activity, e.g. tyrosine 71 [19] and that the
additional nitrations are super£uous. Peroxynitrite has other
actions on proteins, such as nitration or oxidation of trypto-
phan, phenylalanine and cysteine. The modi¢cation of trypto-
phan was suggested by the spectro£uorometric data, at least
at higher concentrations of peroxynitrite. The observed e¡ects
on tissue factor may not, therefore, be exclusively related to
nitration of tyrosine. There are no free thiols in the extracel-
lular domain of tissue factor [19], but tryptophan residues
may contribute to the interactions of tissue factor with Factor
VII as part of the WKS motif [19] : nitration of these residues
may lead to the partial loss of the procoagulant activity of
tissue factor. Phenylalanine is also important in the interac-
tions of Factor VII with tissue factor but at present their
nitration cannot be detected by the spectrophotometric assay
or the ELISA. Free nitrophenylalanine competes with nitrated
bovine serum albumin to a lesser extent than free 3-nitrotyr-
osine in the ELISA which in term is weak related to protein
bound nitrotyrosine [22]. A contribution from nitrated phen-
ylalanine residues in tissue factor cannot be excluded and
deserves further investigation.
Peroxynitrite also oxidises lipids and sugars [1], but the
lipids associated with recombinant tissue factor were not oxi-
dised when recombinant tissue factor was exposed brie£y to
peroxynitrite. As there are no carbohydrate residues in re-
combinant tissue factor, this was not relevant to the impair-
ment of procoagulant activity, but it may in£uence the glyco-
sylated cellular TF. None of the observed e¡ects of
peroxynitrite could be attributed to the presence of residual
H2O2, probably because of the brief duration of the experi-
ments.
It can be concluded that modi¢cation of TF by peroxyni-
trite can bring about inhibition of its activity not only of the
pure protein, but also when located in the cell membrane.
This modi¢cation may occur through actions on di¡erent ami-
no acids, but the nitration of tyrosine appears to be represen-
tative of the changes.
Modi¢cation of tissue factor protein may a¡ord a self-reg-
ulatory process in which unwanted surface procoagulant ac-
tivity may be limited by the release of NO and formation of
peroxynitrite: human monocytes are also capable of NO syn-
thesis in substantial quantities [10]. This modi¢cation may not
be a permanent in vivo as the nitration of tyrosine residues in
platelet cytosolic proteins has been shown to decrease after
the initial action of peroxynitrite [29]. Ultimately the e¡ects of
endogenous peroxynitrite from macrophages or other cell
types on TF function will need to be demonstrated.
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